Compounds > sk&f 81297
Page last updated: 2024-10-21

sk&f 81297 and Dyskinesia, Medication-Induced

sk&f 81297 has been researched along with Dyskinesia, Medication-Induced in 13 studies

Research Excerpts

ExcerptRelevanceReference
" Mild and advanced parkinsonism in nonhuman primates can be produced with fixed dosing regimens of MPTP."1.31D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys. ( Goulet, M; Madras, BK, 2000)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (30.77)18.2507
2000's4 (30.77)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flores, AJ1
Bartlett, MJ1
Root, BK1
Parent, KL1
Heien, ML1
Porreca, F1
Polt, R1
Sherman, SJ1
Falk, T1
Dupre, KB6
Ostock, CY3
George, JA1
Eskow Jaunarajs, KL2
Hueston, CM1
Bishop, C5
Lindenbach, D1
Conti, MM1
Cruz, AV1
McCoy, AJ1
Delaville, C1
Gerber, CM1
Eyring, KW1
Walters, JR1
Eskow, KL1
Barnum, CJ1
Jaunarajs, KL1
Steiniger, A1
Klioueva, A1
Moore, A1
Kelly, C1
Button, T1
Savage, LM1
Wolf, W1
Malik, P1
Andersen, MB1
Peacock, L3
Lublin, H3
Gerlach, J3
Mørkeberg, F1
Goulet, M1
Madras, BK1
Andringa, G1
Vermeulen, RJ1
Drukarch, B1
Renier, WO1
Stoof, JC1
Cools, AR1

Other Studies

13 other studies available for sk&f 81297 and Dyskinesia, Medication-Induced

ArticleYear
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia.
    Neuropharmacology, 2018, Volume: 141

    Topics: Animals; Antiparkinson Agents; Benzazepines; Dizocilpine Maleate; Drug Synergism; Dyskinesia, Drug-I

2018
Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.
    ACS chemical neuroscience, 2013, May-15, Volume: 4, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Benzazepines; Dopamine Agonists;

2013
Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.
    Neuroscience, 2015, Dec-03, Volume: 310

    Topics: AIDS-Related Complex; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Dyskinesia, Dr

2015
Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Neurobiology of disease, 2016, Volume: 86

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzazepines; Disease Models, Animal; Dopamine Agon

2016
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
    Neuropharmacology, 2008, Volume: 55, Issue:8

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Animals; Benzazepines; Biogenic Monoamine

2008
Serotonin 1B receptor stimulation reduces D1 receptor agonist-induced dyskinesia.
    Neuroreport, 2009, Sep-23, Volume: 20, Issue:14

    Topics: Adrenergic Agents; Animals; Benzazepines; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Mal

2009
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.
    Experimental neurology, 2011, Volume: 229, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiparkinson Agents; Benserazide; Benzazepines; Ch

2011
The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 78, Issue:4

    Topics: Animals; Benzazepines; Benzothiazoles; Cebus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 R

2004
Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Psychopharmacology, 1994, Volume: 114, Issue:3

    Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzofurans; Cebus; Dopamine Agonis

1994
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Benzazepines; Dopamine Agen

2000
The validity of the pretreated, unilaterally MPTP-treated monkeys as a model of Parkinson's disease: a detailed behavioural analysis of the therapeutic and undesired effects of the D2 agonist quinpirole and the D1 agonist SKF 81297.
    Behavioural pharmacology, 1999, Volume: 10, Issue:2

    Topics: Animals; Arm; Behavior, Animal; Benzazepines; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonia;

1999
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Clinical neuropharmacology, 1992, Volume: 15, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal;

1992
The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment.
    European journal of pharmacology, 1990, Sep-04, Volume: 186, Issue:1

    Topics: Animals; Antipsychotic Agents; Benzazepines; Blinking; Cebus; Dopamine Agents; Dyskinesia, Drug-Indu

1990